In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

We recently compiled a list of the Morgan Stanley’s 15 Best European AI Stocks. In this article, we are going to take a look ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...

In this article, we are going to take a look at where Merck KGaA (OTC:MKGAF) stands against Morgan Stanley's other European AI stocks. In August last year, investment bank Morgan Stanley released ...

Summer camp registration at Merck Forest & Farmland Center officially opens on February 7 at 9 a.m. With programs designed ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver ...

Merck KGaA and Pfizer have got the fourth checkpoint inhibitor to market after the US regulator approved their avelumab for a rare form of skin cancer. The FDA’s approval of avelumab ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.

Merck Serono, a division of German's Merck KGaA, has announced a new five-year clinical development agreement with Quintiles. This strategic collaboration is the first-of-its-kind between a ...